We are live on ! Find out more
TPI

Tianyin Pharmaceutical
TPI

Delisted

TPI was delisted on the 29th of April, 2016.

5 hedge funds and large institutions have $297K invested in Tianyin Pharmaceutical in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

0.49% less ownership

Funds ownership: 7.18% → 6.69% (-0.49%)

44% less funds holding

Funds holding: 9 → 5 (-4)

88% less capital inflows, than outflows

Capital inflows: $3.3K | Capital outflows: $27.4K

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 4

Holders
5
Holders Change
-4
Holders Change %
-44.44%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

TPI Hedge Fund Activity: Q1 2016 in Review

5 of the 3,768 institutional investors tracked by Wall St. Rank reported a position in Tianyin Pharmaceutical (TPI) for Q1 2016, worth a combined $297K — down 16% from $352K a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of TPI and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Renaissance Technologies, adding an estimated $3.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $18K sold.

  • 5 institutional investors held Tianyin Pharmaceutical (TPI) as of Q1 2016, down from 9 in Q4 2015.
  • Funds reported $297K of Tianyin Pharmaceutical stock for Q1 2016, down 16% quarter-over-quarter.
  • 0 funds opened new Tianyin Pharmaceutical positions in Q1 2016 and 4 closed out, a net change of -4 holders.
  • The largest Tianyin Pharmaceutical buyer in Q1 2016 was Renaissance Technologies, an estimated $3.3K added.
  • The largest Tianyin Pharmaceutical seller in Q1 2016 was Citadel Advisors, an estimated $18K sold.

Based on aggregated 13F filings for Q1 2016.